Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zishui Daohuo Oral Solution and Kujiu Mouthwash for Severe Radiotherapy-induced Oral Mucositis
NCT07339774Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Zishui Daohuo and imatinib in oral mucositis (OM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Duration of severe oral mucositis (RTOG grade>=3). Started Mar 2026; status: recruiting.
02
Drugs
Zishui Daohuoimatinib
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07339774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07339774.